A House committee trying to understand how the opioid crisis came to be and what to do next has set a May 8 hearing for drug distributors to explain their role.
While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.
McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.
President Trump made a long-awaited announcement of his administration's opioid plan in a New Hampshire speech that was part policy roll out and part political rally.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below.
If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener:
http://www.thestreet.com/k/qr/flat/stock-screener.html
Upgrades: CAH, QEP, RGEN, THC, WD
Downgrades: AUTO, FDUS, INTT, OLP, SIM, STRA, VALE
Initiations: ORGS
Read on to get TheStreet Quant Ratings' detailed report:
A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.
After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and distributors operate.
Could Amazon be lost in the jungle when it comes to the drug supply chain? RBC analysts say it's possible. Don't count on a big entrance for at least a few years.
McKesson and Cardinal Health are alleged to have sent more than 12 million opioid doses to a single pharmacy in West Virginia over an eight-year period, according to a House committee probe.
As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?
The stocks of healthcare giants such as United, Cigna and Anthem tumbled Tuesday following news that Amazon, Berkshire Hathaway and JPMorgan have banded together on a healthcare initiative for their workers.